Poland is rolling out Biogensspinal muscular atrophy (SMA) therapy Spinraza (nusinersen) at a faster pace than any country that has approved it, Polish experts say.
Since the first injection in May 2019, about 400 of the 830 patients in Polands SMA registry have either started taking Spinraza or been put on a waiting list to obtain it, according to Kacper Rucinski, president of Warsaw-basedFundacja SMA. A commission of top neurologists is steadily adding patients to the list after determining that they qualify for National Health Service coverage of the treatment.
Longtime SMA expert Anna Lusakowska, a doctor at the Warsaw Medical University Neurology Clinic, predicted that Polish patients who want Spinraza will eventually get the medicine.
However, not all 830 will opt for it, said Rucinski, who along with Lusakowska spoke with SMA News Today by phone. Some patients with the muscle-wasting disease are receiving Roches risdiplam or Novartis branaplam in clinical trials. They would likely stay with their current treatments once those two medications are approved by the Health Ministry and covered by the national health insurance program.
Spinraza is very expensive; both risdiplam and branaplam also will be, upon approval. The U.S. retail price of Spinraza is $750,000 for the first year and $375,000 in subsequent years, although Poland, like all members of the European Union, negotiated its own price with Biogen.
Spinraza first became available in 2017 to a few dozen Polish patients under Biogens expanded-access program. In December 2018 18 months after Spinraza received European Union approval Poland authorized its National Health Service to pay for it.
Hospitals in three of Polands 16 regions spearheaded Spinraza treatment in 2017. Lusakowskas hospital, in the Masovia region which includes Warsaw joined them last year.
Not only did most of the regions outside Warsaw have no experience with Spinraza; they had never even treated SMA patients before, said Lusakowska, who started Polands SMA registry in 2010.
About 120 of Polands SMA patients live in the Warsaw area. As a result, the neurology programs at Warsaw Medical University and Childrens Memorial Health Institute in Warsaw became leaders in treating the disease decades ago.
After the national health insurance program began covering Spinraza, Lusakowskas neurology department decided to administer the medicine to as many people with SMA as possible. Thats led to long hours for staffers, but also has allowed Lusakowskas team to develop a level of expertise solid enough to share with inexperienced practitioners in other regions.
Patients with severe curvature of the spine are a special challenge, even if they have had previous surgery to correct their scoliosis, she said.Radiologists at Lusakowskas clinic use a computerized tomography (CT) scanner to administer injections to individuals with badly curved spines. The scanner shows the best locations for injecting those with scoliosis.
Four months after Polands first non-early-access injection, all regions are offering Spinraza, although it hasnt been easy, Lusakowska said. The surge in Spinraza patients since May has overwhelmed neurological clinics, which in addition to SMA deal with strokes, epilepsy and many other nerve-related conditions.
Lusakowska began her neurology career as an SMA specialist in the mid-1990s, just asscientists were discovering the cause of SMA defects in the SMN1 gene.She and other SMA specialists hoped researchers would develop a therapy quickly.
I worked with SMA patients for 30 years before a treatment came, Lusakowska said. Its really wonderful that I can finally do something for them.
The first Spinraza injection is emotional for patient, family and doctor alike, she said.
Usually the patient cries, the mother cries they have been waiting such a long time for this, she said.
Lusakowska said she can deal with the expressions of joy, even if they include tears. Its harder when the emotion is the anguish of patients calling to complain that they have had to wait such a long time for Spinraza but are still not receiving it, she said.
Like most countries, Poland prioritizes Spinrazas roll-out by age and disease severity. Children younger than 3 years old withSMA type 1 the worst form of the disease get top priority because research has shown they can benefit the most.
Adults with advanced stages of SMA are believed to gain less from treatment, though the main focus of Lusakowskas clinic is adults. She and her colleagues are administering Spinraza to 35 people in their 20s and older with different types of SMA, and expect to treat 70 eventually.
The 35 include seven type 1 patients. Six began taking Spinraza in Belgium under the expanded-access program, but returned to Poland after the National Health Service agreed to cover the treatment costs. The clinic also treats several children above the age of 3.
Lusakowska said Spinraza benefits all her SMA patients. Some improvements are obvious to doctors, while others are not but patients say it is helping them. Within a year, her clinic will have enough month-to-month, muscle-strength comparison data for a scientific assessment of Spinrazas effectiveness.
Some improvements have been amazing, Lusakowska said. That is the case, for example, with a 4-year-old Polish girl with SMA type 2 who began taking Spinraza in France when she was a few months old. Doctors had diagnosed her SMA in the womb after her older brother developed type 2. He also receives Spinraza.
Her brother is improving all the time with Spinraza, Lusakowska said. He is not walking, but he is much stronger. But his sister, who began receiving Spinraza when she was 3 months old, is walking, jumping, dancing shes a normal girl.
Another heartening sign is that, thanks to Spinraza, some patients who had been on detachable ventilation devices 16 hours a day have been able to reduce that to 10 hours a day.
Similarly, some patients say their voices are becoming much stronger as Spinraza strengthens their larynx muscles, Lusakowska said.
She praised the Health Ministry for deciding to cover all SMA patients who want Spinraza, rather than restricting it only to those in certain categories.
We dont have to turn anyone away, she said. We can tell all our patients that maybe not this month, but next month, we can treat you.
Hal Foster is a veteran journalist at the Los Angeles Times and other news organizations in the United States and Japan, and a longtime journalism professor.In addition to the LA Times, he worked at the Portland Oregonian and the Seattle Post-Intelligencer, was executive editor of Pacific Stars & Stripes in Tokyo, and wrote about the war in Ukraine for USA Today.He has a Ph.D. in journalism from the University of North Carolina, and has taught in the United States, Kazakhstan and Ukraine, where he was a Fulbright scholar.
Total Posts: 85
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
More here:
Nearly Half of Poland's SMA Patients on Track to Get Spinraza, Experts Say - SMA News Today
- Home Page of the Human Gene and Cell Therapy Center [Last Updated On: August 29th, 2015] [Originally Added On: August 29th, 2015]
- Gene Therapy: Chinese Researching Gene Replacement [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Medi-Cal: Medi-Cal Update - Clinics and Hospitals | May ... [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Gene Therapy Market - Size, Share, industry, Forecast ... [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
- Digital Journal: A Global Digital Media Network - Digital Journal (press release) [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Cure for ageing could lie in gene therapy | WIRED UK [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Advanced Gene-Targeted Therapies - Alternative Cancer Clinics [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Alternative Cancer Clinics - Immunotherapy for Cancer [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Stem cell therapies breaking barriers - Guardian (blog) [Last Updated On: July 9th, 2017] [Originally Added On: July 9th, 2017]
- Cancer Biological Therapy market is rising with potential rate at CAGR of 4.7 % till 2023 - MENAFN.COM [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Head and Neck Cancer Therapeutics Market is Expected to Generate Huge Profits by 2024 - MilTech [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- In a first, scientists edit fatal gene mutation out of DNA - Asheboro Courier Tribune [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Proton Therapy: How It Could Change The Outcome of Paediatric Cancer - HuffPost [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Wilson's Disease Market: Unmet Needs of Patient Population to Inspire Players for Improved Treatment Options - Edition Truth [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Cardiovascular disease cure? One session of THIS could help treat condition - Express.co.uk [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Understanding the muscle behind global duchenne muscular dystrophy market - WhaTech [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Biological bypass shows promise in coronary artery disease - Medical Xpress [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Sodium Iodide Symporter for Nuclear Molecular Imaging and ... [Last Updated On: August 13th, 2017] [Originally Added On: August 13th, 2017]
- Traditional Therapy Clinics Ltd (TTC.AX) Money Flow Index Levels in Focus - Stock Daily Review [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Gene Editing in Human Embryos Leaps ForwardHere's the Science - Singularity Hub [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Global Cancer Biological Therapy Market 2017 Size, Development Status, Type and Application, Segmentation ... - Digital Journal [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Orphan Diseases Market Key Players analysis ... - Digital Journal - Digital Journal [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- New Stanford drug saves child with deadly genetic disease - The Mercury News [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- Australian Market Declines - Markets Insider [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- How one California county is fighting high-priced surgeries - Los Angeles Times [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Global Cancer Biological Therapy Analysis & Forecast 2016 to 2023 - Digital Journal [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA Approves New Cancer Treatment - Alive For Football [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA approves first cell-based gene therapy for use in the United States - Gears Of Biz [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Quick Hits: Withdrawn Leukemia Drug Returning, Drugmaker in $58M Settlement Over Sales Reps, and More - MedShadow (registration) (blog) [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Hacking Your Genes Has Never Been Easier - Outside Magazine [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- resurrection-clinics.eu [Last Updated On: August 24th, 2018] [Originally Added On: August 24th, 2018]
- Cell and Gene Therapy Center - IQVIA [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
- F.D.A. Speeds Review of Gene Therapies, Vowing to Target ... [Last Updated On: February 17th, 2019] [Originally Added On: February 17th, 2019]
- Nutrition : The Addiction Recovery Guide [Last Updated On: March 25th, 2019] [Originally Added On: March 25th, 2019]
- Gene Therapy: The New Frontier for Inherited Retinal Disease [Last Updated On: April 16th, 2019] [Originally Added On: April 16th, 2019]
- 4 Barriers To Cell And Gene Therapy Development For Rare ... [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Google Bans Advertising on Unproven Medical Treatments (like Stem Cells) - Bedford Bulletin [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Biological Product Manufacturing Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast - Rapid News Network [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market to Witness Comprehensive Growth by 2017 2025 - Technology Trend [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Targeted Cancer Therapies Market Regional Landscape, Production, Sales & Consumption Status and Prospects 2025 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Chemotherapy Drugs Market Strategies, Major Industry Participants, Marketing Channels and Forecast To2018 2028 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Texas State To Expand Round Rock Campus Programs, Services - Round Rock, TX Patch [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Transfusion-dependent Anemia Treatment Market Size, Status and Growth Opportunities by 2025 - The Market Plan [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Google bans ads for 'bad actors' selling 'deceptive treatments' - BioEdge [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market Forecast Research Reports Offers Key Insights 2017 2025 - Space Market Research [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Prospective Study Characterizes PCa Risk Linked to BRCA1, BRCA2 Mutations - Renal and Urology News [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Pollard and Norris in the race for Pos. 2 of the Public Hospital District 4 - Snoqualmie Valley Record [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Social Impact Heroes: How Lynn OConnor Vos and the Muscular Dystrophy Association are helping to raise billions of dollars to fund research to... [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Non-viral Gene Therapy will now accelerate cancer study - Industry Reporter [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Transfusion-dependent Anemia Treatment Market Gain Impetus due to the Growing Demand over 2019 2029 - Herald Space [Last Updated On: October 1st, 2019] [Originally Added On: October 1st, 2019]
- Parkinsons Disease Treatment Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2025 - The Ukiah Post [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- The Patient Perspective On Patient Centricity Insights From A Veteran Of 5 Clinical Trials - Clinical Leader [Last Updated On: October 12th, 2019] [Originally Added On: October 12th, 2019]
- Deepak Chopra Has Never Been Sick - The New Yorker [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Dr Batra's have launched a new genetics-based therapy that predicts future diseases - Gulf Today [Last Updated On: October 31st, 2019] [Originally Added On: October 31st, 2019]
- Davenport & Company Upped By $3.56 Million Its Sgmo (SGMO) Holding; EMPOWER CLINICS ORDINARY SHARES (EPWCF) Shorts Raised By 2360% - MS Wkly [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Global Cell Therapy Technologies Market Industry Analysis And Forecast (2018-2026) - The Market Expedition [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Tip Sheet: A clever way to make an AIDS vaccine; how a common cancer mutation actually drives cancer; and a new process that regulates red blood cell... [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Anti-Aging Products and Therapies Market Outlook: Investors Still Miss the Big Assessment - The Market Journal [Last Updated On: November 11th, 2019] [Originally Added On: November 11th, 2019]
- Abuse in cell banking services a global problem - Bioprocess Insider - BioProcess Insider [Last Updated On: November 14th, 2019] [Originally Added On: November 14th, 2019]
- Hemophilia Treatment Market Dynamics, Pin-Point Analysis, Comprehensive Landscape, Demand Key Factors, Market Segments Regions, Therapy For Hemophilia... [Last Updated On: November 18th, 2019] [Originally Added On: November 18th, 2019]
- U.S. stem cell clinic offering unapproved therapies brings direct-to-consumer marketing to Ottawa - Ottawa Citizen [Last Updated On: November 18th, 2019] [Originally Added On: November 18th, 2019]
- Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT - Yahoo Finance [Last Updated On: November 20th, 2019] [Originally Added On: November 20th, 2019]
- Macular Degeneration Treatment Market and its Future Outlook and Trend During the Period of 2019 2026 - The Chicago Sentinel [Last Updated On: November 25th, 2019] [Originally Added On: November 25th, 2019]
- Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - Thehour.com [Last Updated On: November 28th, 2019] [Originally Added On: November 28th, 2019]
- Global Parkinsons Disease Treatment Market 2019 Analysis by Industry Growth, Size, Share, Trends and Forecast by 2025 - Eastlake Times [Last Updated On: November 30th, 2019] [Originally Added On: November 30th, 2019]
- World AIDS Day 2019: 37.9M people worldwide were living with HIV at the end of 2018 - USA TODAY [Last Updated On: December 2nd, 2019] [Originally Added On: December 2nd, 2019]
- Precision Cancer Therapies Market Size, Status and Forecast 2025 Trends, Size, Drivers, Strategies, Products and - The Market Stats News [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Counterculture 73: Summer Jam, Timothy Leary and the Sexual Revolution - Rolling Stone [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Cancer gene therapy backed by Blackstone gets trial win - BioPharma Dive [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Parkinsons Disease Treatment Market 2019- Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Tribunal... [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Mergers and Acquisitions Will Strengthen Payer Identity in 2020 - HealthPayerIntelligence.com [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- University of Iowa researchers say $18 million grant could soon lead to cure for rare brain disease - KCRG [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- ICMR issues guidelines for gene therapy in India - Daily Pioneer [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- US Network of Specialized Angelman Clinics to Double Thanks to New Partnership - Angelman Syndrome News [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- This was the best health news over the last decade - USA TODAY [Last Updated On: December 18th, 2019] [Originally Added On: December 18th, 2019]
- Top Providers of the Alpha Thalassemia Market gives a New Dimension easing Measurement and Quantification - GuruFocus.com [Last Updated On: December 27th, 2019] [Originally Added On: December 27th, 2019]
- Novel discovery in gene therapy to treat kidney diseases - WeForNews [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Insights on precision oncology developments in Japan and beyond - MobiHealthNews [Last Updated On: January 6th, 2020] [Originally Added On: January 6th, 2020]
- Cell Harvesting Market is Expected to Reach USD 387.9 Million by 2025| Bertin, Tomtec, Terumo BCT, HynoDent AG, Avita Medical, Argos Technologies -... [Last Updated On: January 9th, 2020] [Originally Added On: January 9th, 2020]